Weekly shot tested as potential new Alzheimer's treatment
NCT ID NCT03748303
Summary
This study tested a weekly injection of a medication called allopregnanolone for people with early Alzheimer's disease. The main goal was to find a safe and effective injection dose that works as well as an IV dose. Researchers also wanted to see if the medication could be given safely by a nurse at home.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DEMENTIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Southern California - Alzheimer Disease Research Center - Healthcare Consultation Center II
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.